Related by context. All words. (Click for frequent words.) 65 Stent Graft 64 Ablation System 64 Announces FDA Clearance 64 AneuRx AAAdvantage 63 urethral bulking agent 62 ORLive Presents 62 Bioresorbable 62 Thoracic Endoprosthesis 62 Absorbable 62 Diabetic Foot Ulcer 62 NAVISTAR R 61 Embolization 61 Dural Regeneration Matrix 61 Cardioblate 61 Receives FDA Clearance 61 Stent Grafts 61 FDA Approvals 61 Drug Eluting 61 Shows Promise Against 61 endoluminal stent graft 61 Bone Metastases 61 Microcatheter 61 Thrombus Aspiration 61 Clinical Study Shows 61 Contrast Agents 61 Gets FDA Clearance 60 IONSYS TM 60 Spinal Disc 60 Files IND 60 Improves Outcomes 60 Completes Enrollment 60 Effectively Treats 60 External Beam 60 Receives Orphan Drug Designation 60 Oral Spray 60 FDA Clears 60 Completes Patient Enrollment 60 Pedicle Screw 60 Non Invasive Treatment 60 infrarenal 60 PROMUS TM 60 Proves Effective 59 Appears Safe 59 CT Angiography 59 Endovascular Graft 59 Embolic Protection System 59 Meets Primary Endpoint 59 Intravascular 59 Demineralized Bone Matrix 59 Microwave Ablation System 59 Hsp# Inhibitor 59 FDA Okays 59 Endovascular System 59 Artificial Disc 59 Adsorbent 59 Therapeutic Efficacy 59 Lyophilized 59 Initiates Enrollment 59 Transdermal Patch 59 Receives Approvable Letter 59 FDA Clearance 59 Brain Metastases 59 Spinal Fusion 59 Teva Provides Update 59 Prolongs Survival 59 Left Atrial Appendage 59 MR Angiography 59 Minimally Invasive Procedure 59 Wound Dressing 59 Vitrectomy 59 Demonstrates Potential 59 Pulsatile 59 Ultrasound Guided 59 Study Shows Benefits 59 Carotid 58 Reduces Risk 58 Vascular Graft 58 Embolic 58 Long Term Efficacy 58 injectable bulking agent 58 Drug Eluting Coronary Stent 58 Skin Grafts 58 Pedicle Screw System 58 Begins Shipment 58 Anterior Cervical 58 Myocardial Perfusion Imaging 58 Pericardial 58 Demonstrates Positive 58 Shows Promising 58 Osteoporosis Treatment 58 Demonstrates Significant 58 Test Detects 58 Catheter Associated 58 Aortic Valve 58 Achieves Primary Endpoint 58 Endologix Powerlink System 58 Contrast Enhanced 58 Resection 58 Vascular Grafts 58 Soft Tissue Sarcoma 58 Artery Disease 58 Anastomosis 58 Patients Undergoing 58 Embolic Protection 58 Patients Treated With 58 Nerve Stimulation 58 Reduces Mortality 58 Therapy Improves 58 Cardiac Output 58 JAK2 Inhibitor 58 Clinical Trial Evaluating 58 vinorelbine tartrate 58 Soft Tissue 58 Announces License Agreement 58 Breast Biopsy 58 Microspheres 58 Node Positive 58 Low Dose 58 Thrombectomy System 58 Successfully Treats 58 Ultrasonic Wound 58 IND Application 58 Platinum Chromium 58 Transdermal Delivery 58 Reduced Risk 58 Balloon Catheters 57 Phase III Clinical Trial 57 Embolic Protection Device 57 Sirolimus eluting 57 Adjuvant Treatment 57 Thrombotic 57 Investigational Treatment 57 Sign Licensing Agreement 57 Replacement Therapy 57 Renal Cell Carcinoma 57 Bacteremia 57 Files Patent Application 57 TM Embolic Protection 57 Single Dose 57 Talent Abdominal 57 Diabetic Neuropathy 57 Proven Effective 57 Therapy Reduces 57 Improves Survival 57 Accelerated Partial Breast Irradiation 57 Bioabsorbable 57 First Patient Treated 57 Patients Receiving 57 AnaSpec Introduces 57 GORE VIABAHN ® 57 Awarded Patent 57 Resorbable 57 Receives CE Marking 57 Occlusion 57 Emboshield 57 Aortic Valve Replacement 57 Drug Candidate 57 treating abdominal aortic 57 Chemoradiation 57 Endometrial Cancer 57 Secca System 57 Adjuvant Chemotherapy 57 Could Save Lives 57 Introduces Revolutionary 57 Demonstrates Statistically Significant 57 Protein Synthesis 57 liver resection surgeries 57 Antiarrhythmic 57 Prognostic Factors 57 Risk Stratification 57 Levels Linked 57 Fungal Infections 57 Initiates Clinical Trial 57 Biliary System 56 Develop Novel 56 Sign License Agreement 56 Lowers Cholesterol 56 HER2 Positive 56 Hematopoietic 56 Fractionated 56 Contaminant Found 56 Antitumor Activity 56 Trobalt 56 Files Investigational 56 Fixation System 56 acetonide FA 56 Drug Prevents 56 Commences Phase 56 hypervascular tumors 56 Hemodialysis Patients 56 Recurrent Glioblastoma 56 Soft Tissue Sarcomas 56 Announces Tentative Approval 56 Secondary Hyperparathyroidism 56 novel oral anticoagulant 56 Coronary Arteries 56 Interferon Alpha 56 Initiate Clinical Trial 56 PICCs 56 Advanced Melanoma 56 Adjuvant Therapy 56 REMINDER ORLive Presents 56 Fondaparinux 56 Surgical Mesh 56 Vascular Inflammation 56 Mouse Model 56 Treating Chronic 56 Treatment Reduces 56 Inhaled Nitric Oxide 56 Syneron logo 56 Diamondback #deg 56 Allograft 56 Named Exclusive Distributor 56 Percutaneous Tibial Nerve Stimulation 56 Minimally Invasive Treatment 56 Less Invasive 56 Antidepressants Linked 56 Intravesical 56 Glaucoma Treatment 56 mechanical thrombectomy 56 Shows Efficacy 56 Receives Patent 56 Chronic Heart Failure 56 Oral Calcitonin 56 Tyrosine Kinase Inhibitor 56 Coronary Angiography 56 Phase 2a Clinical Trial 56 Interbody 56 Taclonex R 56 Intra Arterial 56 Peripheral Arterial 56 Controlled Trial 56 Confirms Significant 56 Eases Pain 56 Phakic 56 Reduces Pain 56 Initiates Phase II 56 Cervical Plate 56 Interspinous 56 Topical Treatment 56 Medoxomil 56 Stress Urinary Incontinence 56 Pegylated Liposomal Doxorubicin 56 Pharmaceuticals Initiates 56 Exposure Linked 56 ImmuKnow R 56 Robotic Assisted 56 candidates Azedra TM 56 PATHFINDER ® TRACER 56 vapreotide acetate 55 Arterial Disease 55 HepaSphere 55 Prophylactic Treatment 55 Migraine Treatment 55 Fluorouracil 55 BrachySil ™ 55 Atopic Dermatitis 55 topically applied SEPA 55 METOZOLV TM ODT metoclopramide 55 Augment TM 55 Allogeneic 55 Respiratory Virus 55 Bucindolol 55 Warfarin Coumadin 55 hyaluronidase enzyme 55 Heart Transplant Recipients 55 Submits NDA 55 Arteriovenous 55 Water Soluble 55 Obtains Patent 55 Antithrombin 55 Announce Licensing Agreement 55 Device Helps 55 Zolpimist ™ 55 Dual Wavelength 55 Zicam Cold Remedy RapidMelts 55 Recurrent Breast Cancer 55 TNF Tumor Necrosis Factor 55 novel emulsion formulation 55 Infusion System 55 Simulect 55 Aortic Aneurysm 55 Study Proves 55 Introduces Next Generation 55 Hormone Refractory Prostate Cancer 55 Ablation 55 Anterior Cervical Plate 55 Bone Void Filler 55 Ultrasound Imaging 55 Valvular 55 Unfractionated Heparin 55 Hemostatic 55 platform HDL Mimetic 55 Enzymatic 55 Hydralazine 55 HuMax Wnt 55 Announces Licensing Agreement 55 Ischemic 55 ATS Simulus R 55 Coronary Artery Bypass Graft 55 Osteotomy 55 Introduces Novel 55 Spinal Fractures 55 HALO# [001] 55 metastatic malignant 55 Adipose Derived Stem Cells 55 Schizophrenia Treatment 55 Proves Successful 55 INTELLITEMP ® Energy 55 Bosutinib 55 Announce Collaboration Agreement 55 Phase 2b Trial 55 Renal Cancer 55 Amends Agreement 55 Significantly Increases 55 Antitumor 55 Intracerebral Hemorrhage 55 Announce License Agreement 55 Bone Cement 55 Phase IIa Clinical Trial 55 Roche Boniva 55 Helps Prevent 55 thalidomide Thalomid 55 Unigene nasal calcitonin 55 Signs Option Agreement 55 superficial femoral 55 Recall Issued 55 Cobalt Chromium 55 Submits Application 55 Tumor Response 55 Demonstrates Efficacy 55 Postmenopausal Osteoporosis 55 Could Detect 55 Radioimmunotherapy 55 FDA Approves Drug 55 Gastrointestinal Tract 55 Novel Oral 55 Intracranial 55 Helps Diagnose 55 Develops Innovative 55 Intramedullary 55 FDA Warns Against 55 GORE ® 55 FDA Panel Recommends 54 DuraGen Plus 54 Anthracycline 54 SPL# Gel vaginal microbicide 54 Endovascular Treatment 54 Levacor TM 54 Protein Linked 54 Neuroendocrine Tumors 54 Assay Kits 54 Left Ventricular 54 paclitaxel poliglumex 54 Dyloject TM 54 ADP receptor antagonist 54 Stress Induced 54 Orally administered 54 HeartMate R 54 Oxygen Saturation 54 Liver Metastases 54 Vaginal Gel 54 AVI BioPharma Announces 54 HCl Injection 54 Nicotine Vaccine 54 VALSTAR TM 54 AMPLATZER ® 54 Clinical Trial Results 54 Lowers Risk 54 Neovascularization 54 Recombinant Human 54 MKC# MKC# PP 54 Anti Tumor Activity 54 Renal Impairment 54 Annuloplasty 54 Spinal Implant 54 Anti Tumor 54 Solvent Based 54 Unveils Innovative 54 leiomyomas 54 Levoleucovorin 54 Commercializes 54 Aortic 54 Fibrinogen 54 Total Knee Arthroplasty 54 Chronic Sinusitis 54 Prove Effective 54 Occluder 54 Juvederm Restylane 54 Hyperparathyroidism 54 HuMax 54 Receives Marketing Authorization 54 Increased Mortality 54 Pharmacokinetics PK 54 Nail Fungus 54 Liposomal 54 Present Preclinical Data 54 Européenne Mark 54 Osteoporosis Drugs 54 Fludara ® 54 Circulating Tumor Cells 54 transurethral 54 AFREZZA TM 54 Initiates Clinical 54 adenosine injection 54 Mg Usa 54 Hypertriglyceridemia 54 Intubation 54 Acute Ischemic Stroke 54 Spinal Fluid 54 BioSante Pharmaceuticals Announces 54 Acquires Exclusive 54 Posaconazole 54 Thiazolidinediones 54 PROMUS Element 54 Genital Warts 54 PERLANE 54 Cook Zenith TX2 54 Cardiovascular Disease Risk 54 Inhaled Corticosteroids 54 Vitrasert R 54 Needleless 54 Successfully Tested 54 Inks Licensing Deal 54 Novel Therapeutic 54 Receives CE 54 NUVIGIL ® 54 Prognostic Value 54 Esophageal 54 Microplasmin 54 Attenuates 54 Patient Treated 54 Ovarian Cancers 54 Intravenous Human 54 Osteoporosis Drug 54 Sevelamer 54 R Perfexion TM 54 molecular imaging radiopharmaceutical 54 mertansine 54 Neoadjuvant Chemotherapy 54 Amplatzer 54 Oropharyngeal Candidiasis 54 NDA Submission 54 Localized Prostate Cancer 54 Eluting Stent 54 Cryoablation 54 acute peripheral arterial 54 miconazole Lauriad ® 54 Emphasys 54 Slows Progression 54 Delivery Catheter 54 Transurethral 54 Hydrophilic 54 Aloprim TM allopurinol sodium 54 Tissue Engineered 54 Predict Response 54 Myoblast 54 Chronic HCV 54 Injectable Bone Graft 54 Progressive Multifocal Leukoencephalopathy 54 Bioartificial Liver 54 Raw #/#/# Punjab 54 Lowers Blood Pressure 54 Cocaine Addiction 54 kidney urologic 54 Lysis 54 DUROLANE 54 SilverHawk Plaque Excision System 54 Enters Into Exclusive 54 Oxybutynin 54 Immunoassay System 54 Prodrug 54 Venous Thrombosis 54 Vertebral 54 See CLINICAL PHARMACOLOGY 54 Mitomycin C 54 Neurotransmitter 53 Occlusive 53 minimally invasive Percutaneous Myocardial 53 Novel Compound 53 Identifies Potential 53 Benephit 53 Interferon Gamma 53 Differential Diagnosis 53 CYT# potent vascular disrupting 53 Distal Radius 53 Cholesterol Lowering Drug 53 Confirmatory Phase 53 Regenerative Cell 53 Intramuscular 53 Intracerebral 53 Demonstrate Significant 53 REVELATION ® Series 53 Rilonacept 53 Pegloticase 53 Introduces Breakthrough 53 Estrogen Receptor 53 Adjunctive 53 Novel Antibiotic 53 TNF Blockers 53 Surgical Sealant 53 Hernia Repair 53 Wins Patent Infringement 53 Electrosurgical Generator 53 Further Validates 53 Being Studied 53 Intracranial Aneurysms 53 Vacuum Assisted Closure 53 CD HORIZON 53 Orthostatic Hypotension 53 Beta Blocker 53 received CE Conformité 53 Capsular 53 PRN FDA Approves 53 Bifurcated 53 Neoplasms 53 Kidney Function 53 Erythropoietic 53 percutaneous injection 53 targeted radiotherapeutic 53 Epidermal Growth Factor Receptor 53 Plaque Psoriasis 53 Breast Cancer Cells 53 Dynamic Stabilization 53 Gastroesophageal Reflux Disease 53 Hemostat 53 Cardica Microcutter XPRESS 53 Mg Uk 53 Axillary 53 Announces Initiation 53 Signaling Pathway 53 Obese Patients 53 Breast Biopsy System 53 unresectable inoperable 53 Combo Therapy 53 Resubmission 53 Adenomas 53 Regenerative Cells 53 Thrombus 53 Prolonged Exposure 53 renal artery stenting 53 Aspheric 53 Endometrial Ablation 53 cobalt chromium stent 53 Surgical Hemostat 53 Orally Active 53 Fracture Risk 53 Announce Merger Agreement 53 Angiogenic 53 miconazole Lauriad R 53 Sentinel Lymph Node Biopsy 53 Gene Mutation 53 Tumor Targeting 53 Versus Placebo 53 Lymphoid 53 Circular Saws 53 wilate ® 53 Methylnaltrexone 53 Teduglutide 53 CRMD# 53 Aeolus Pharmaceuticals Announces 53 Initiates Clinical Trials 53 Prostatic 53 Complicated Skin 53 Femtosecond Laser 53 Rheumatoid Arthritis Patients 53 Immunotherapeutic 53 Prostate Biopsy 53 Silodosin 53 Fibrin Sealant 53 treat benign prostatic 53 Protein Expression 53 Author Affiliations Division 53 Prostate Cancer Treatment 53 Skin Disorders 53 TriActiv R 53 Capecitabine 53 Stromal 53 EnteroMedics proprietary neuroblocking technology 53 Ventricular 53 Regrow 53 RIGScan R 53 Calcium Phosphate 53 include Alferon N 53 Shellgel TM injectable viscoelastic 53 TheraSphere R 53 Allografts 53 INSPIRE Trial Phase III 53 Smoking Linked 53 Breast Cancer Recurrence 53 Generx ® 53 bevacizumab Avastin R 53 PICSO ® 53 estradiol transdermal spray 53 Autoantibodies 53 Bacterial Vaginosis 53 AFRS TM 53 selective A2A adenosine receptor 53 Chronic Renal Failure 53 Subarachnoid Hemorrhage 53 DURIN TM 53 ATS Simulus 53 Retains Leading 53 Skeletal Muscle 53 Total Hip Arthroplasty 53 Squamous Cell Carcinoma 53 prescription laxative 53 targeted antifolate 53 automated radiopharmaceutical distribution 53 Chemotherapeutic 53 Nucleoside 53 Adenoviral 53 Molecular Mechanism 53 Multifocal 53 TRANSDUR ™ 53 Cimzia TM 53 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 53 Gastric Cancer 53 Silicone Breast Implants 53 Ventricular Arrhythmias 53 Mandibular 53 PEGylated anti 53 INDUSTRY ASSESSMENTS 53 Pafuramidine 53 Nonsurgical 53 Suture Anchor 53 Itraconazole 53 Bepreve TM 53 nasal decolonization 53 small molecule tyrosine 53 VBLOC TM 53 Enlarged Prostate 53 liposomal formulation 53 Dosage Form 53 Mitral Regurgitation 52 Hemolysis 52 Wound Dressings 52 Obtains Approval 52 Parenteral Nutrition 52 J Shoulder Elbow 52 Detection Evaluation 52 Prostate Cancer Recurrence 52 Pivotal Phase III 52 Melphalan 52 Clot Busting 52 Signs Licensing Agreement 52 Synthetic Peptide 52 Atypical Hemolytic Uremic Syndrome 52 interstitial cystitis painful 52 Renal Cell Cancer 52 essential thrombocythemia ET 52 Settle Patent Litigation 52 Surgical Procedures 52 Infusion Pump 52 Cervical Dysplasia 52 electrosurgical generator 52 Susceptibility Testing 52 Retinoic Acid 52 Hyperuricemia 52 Neurosurgical Products 52 Naturally Occurring 52 Endarterectomy 52 antibiofilm 52 Degenerative Disc Disease 52 Device Maker 52 Completes Merger With 52 papillary thyroid carcinoma 52 CTO recanalization 52 Achieves Unprecedented 52 Critically Ill Patients 52 R Saizen R 52 Confocal Microscopy 52 therefore therapeutically equivalent 52 Cardiotoxicity 52 Associatesfortune.com 52 Carbamazepine 52 Hormone Replacement 52 STARFlex ® 52 Erosive 52 Accelerate Commercialization 52 Tambocor 52 Androgen Deprivation Therapy 52 abobotulinumtoxinA 52 Intrathecal 52 Viscosupplementation 52 Achieves ISO #:# Certification [002] 52 Novel Inhibitor 52 Warner Chilcott Actonel 52 Peptic Ulcer 52 Factor Receptor 52 Phase IIb Clinical Trial 52 Eur J 52 ImmunoCAP ® 52 Tissue Matrix 52 Plasmid DNA 52 Enzyme Replacement Therapy 52 Signs License Agreement 52 ALVESCO ® 52 Hemispherx flagship products 52 Drug Fails 52 Glycosylation 52 Angina pectoris 52 Endocrinol 52 Impairs 52 HepaGam B 52 Artificial Skin 52 3M Completes Acquisition 52 Actifuse 52 Phase III Pivotal 52 Equetro 52 ACUROX 52 BioElectronics Announces 52 Reflow Oven 52 Factor VIIa 52 Heartmate 52 Alferon N 52 buccal spray 52 Inhaled AAT 52 ODT metoclopramide HCl PEPCID 52 Metabolic Disorder 52 OnControl 52 Allergic Reactions 52 ALN HPN 52 Genes Linked 52 Peripherally Inserted Central 52 G CSFs 52 Peginterferon alfa 2b 52 Hepatic 52 aldehyde dehydrogenase ALDH2 deficiency 52 Macroplastique R 52 Endotracheal Tube 52 Suppositories 52 Escitalopram 52 Drug Absorption 52 peripherally acting 52 drotrecogin alfa activated 52 Resistant Hypertension 52 Maleate 52 Non Inferiority 52 Successfully Treated 52 Oral Insulin 52 Can Detect 52 Prevent Stroke 52 Scintigraphy 52 leukopenia pancytopenia thrombocytopenia 52 Hepatitis C Genotype 52 Benign Prostatic Hyperplasia BPH 52 somatostatin analog 52 Knee Implants 52 Data Suggest 52 Degarelix 52 Intraosseous Infusion System 52 Ondansetron Orally Disintegrating Tablets 52 Granulation 52 Metastatic Prostate Cancer 52 adjunctively 52 Interference Screw 52 investigational immunotherapy 52 Laser Ablation 52 MiniArc Precise 52 Terminates Contract 52 occlusion PAO 52 Powerlink ® 52 AMCC QT# 52 Imaging Techniques 52 Caution Urged 52 implanted subcutaneously 52 MOVIPREP R 52 GLP1 INT TM 52 ACTEGA Coatings & 52 Epoprostenol 52 DUROS 52 Image Guided 52 LEUKINE 52 Receives Favorable Ruling 52 Perfusion Index 52 Malignant Glioma 52 Lung Transplants 52 Hip Implants 52 Hip Stem 52 Dural Sealant 52 Weight Loss Supplement 52 VISICOL R 52 Gastrointestinal Stromal Tumors 52 Pelvic Organ Prolapse 52 Irinotecan 52 catheter occlusion 52 Announces Rebranding 52 Announces Conditional Approval 52 Finalizes Acquisition 52 IMPELLA 52 Pre Cancerous 52 Forward Looking IVUS 52 Appoints Experienced 52 Carotid Artery Stenting 52 Positioner 52 Adult Stem Cell Therapy 52 proprietary polysaccharide 52 cisplatin gemcitabine 52 Cardio3KG 52 PICC WAND 52 uricase 52 SABER ™ 52 TO AVOID PREGNANCY WHILE 52 JAK Inhibitor 52 Lymphatic System 52 Breast Implant 52 STARFlex R 52 fosbretabulin 52 HALO# [002] 52 failure ADHF 52 Voluntarily Withdraws 52 Unveils Groundbreaking 52 Electrosurgical 52 Phase IIa Trial 52 solifenacin succinate 52 Chronic Pelvic Pain 52 Disease Progression 52 Announces Proposed Acquisition 52 Blood Clotting 52 cromolyn sodium 52 Tigecycline 52 Hemopurifier ® 52 MRidium 52 Mitral Valve Repair 52 Cellulite Treatment 52 Hip Prosthesis 52 Sumatriptan Succinate 52 Antimicrobial Dressings 52 Auto Injector 52 Sirolimus Eluting Stent 52 Teriparatide 52 Devices PTCs 51 apomorphine hydrochloride 51 BCG refractory carcinoma 51 Left Ventricular Hypertrophy 51 Heel Pain 51 Spinal Cord Stimulator 51 Skin Tightening 51 ® lenalidomide 51 Ultrasonic Surgical Aspirator 51 Lower Extremity 51 Therapeutic Competitors Report 51 Recall Expanded 51 Cancer Patients Treated 51 ATS CryoMaze TM 51 Panzem ® 51 MoxDuo ® 51 IN.PACT Falcon 51 Submits Investigational 51 LibiGel ® 51 Gene Variation 51 Plus STAARVISC TM 51 Transdermal System 51 Fludarabine 51 oral prodrug 51 recurrent metastatic 51 ® decitabine 51 Dermal 51 Inflammatory Pain 51 Autogenous 51 Albumin 51 Integra LifeSciences Announces 51 investigational antiplatelet 51 SANVAR 51 Prompts Recall 51 Engages Investor Relations 51 Successfully Completed 51 ReValving System 51 Progenitor Cells 51 Secures Patent 51 Announces Immediate Availability 51 Immunosuppressant 51 Announces Non Brokered 51 allogeneic hematopoietic cell 51 topically administered 51 Prostate Cancer Vaccine 51 Cyclophosphamide 51 NeuroMove 51 intracavitary 51 Myocardial Perfusion 51 Strengthens Balance Sheet 51 Transfection 51 microcatheters 51 Humate P 51 receptor tyrosine kinase inhibitor 51 MKC# 51 Central Venous Catheters 51 Cystectomy 51 Prostate Cancer Patients 51 OvaRex R 51 Zorbtive TM 51 Corneal Transplant 51 Artelon ® 51 Could Predict 51 Tyrosine Kinase Inhibitors 51 cardioverter defibrillator 51 QuadraSphere 51 Ectopic 51 Receives Orphan Drug 51 systemic immunosuppressive drugs 51 CRT Ds 51 Anturol TM 51 Watchful Waiting 51 Topical Suspension 51 Miconazole 51 Visceral Fat 51 Acne Drug 51 Glufosfamide 51 SoftScan ® 51 Cerebrospinal Fluid 51 Lamotrigine 51 Endothelium 51 Newly Diagnosed Multiple Myeloma 51 HeartMate ® 51 Biomaterial 51 myelodysplastic myeloproliferative diseases 51 paroxetine sertraline 51 Aridol TM 51 LATEST WRESTLING NEWS 51 Develops Novel 51 Tocopherol 51 Multiple Ascending Dose 51 Pharmacologic 51 Vildagliptin 51 ACE Inhibitors 51 Granulocyte Colony Stimulating Factor 51 Dehydrogenase 51 Gout Drug 51 GEMS TM 51 Squamous Cell 51 Epilepsy Drugs 51 Platinol ® 51 Flamel Technologies Announces 51 vascular stent 51 Expand Collaboration 51 Lupus Nephritis 51 Results Confirm 51 triciribine phosphate monohydrate 51 Semi Rigid 51 biliary tract cancer 51 Receptor Antagonists 51 Pharmacodynamics 51 Tibolone 51 Announce Formation 51 PEGylated Fab fragment 51 Anti Fungal 51 Diverter 51 serotonin norepinephrine reuptake inhibitor 51 Cervical Spine 51 Cytarabine 51 ELND-#/AZD-# 51 Spins Out 51 Causes Symptoms 51 MyoSure 51 Intravenous immunoglobulin 51 Sufentanil 51 subependymal giant cell 51 PI3K/Akt pathway inhibitor 51 EP #R 51 NOTES Natural Orifice 51 Ultra Sensitive 51 Saphenous Vein 51 VBLOC ™ 51 Known hypersensitivity 51 Initiates Voluntary 51 Clinically Proven 51 Fulvestrant 51 developing Bicifadine serotonin 51 Bimodal 51 conivaptan 51 topical gel formulation 51 Oral Formulation 51 Inflammatory Diseases 51 Electrical Stimulation 51 Photodynamic 51 REVELATION ® 51 Adverse Event 51 Liver Failure 51 Engages CHF Investor Relations 51 parenterally administered 51 Novel Treatments 51 Soliris eculizumab 51 Mineralization Extended 51 Investigational Oral 51 LLC Mgr 51 NeoLipid R 51 Enters Into Joint Venture 51 Discovery Labs aerosolized 51 Perforomist ™ Inhalation Solution 51 Paroxysmal 51 Serostim ® 51 Healon R 51 Biocompatible 51 Receptor Antagonist 51 Chemokine Receptor 51 Uterine 51 Silicone Gel 51 DEB#